Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03916614 · ClinicalTrials.gov registry record · NA
Relief of Symptoms of Post-traumatic Stress for Victims of Gun Violence
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT03916614: Completed NA study, sponsored by Yale University.
NCT03916614 is a NA study that has completed, run by Yale University. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03916614, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
To test the hypothesis that adult individuals who are victims of gun violence will have decreased symptoms of post-traumatic stress after an individual-level intervention with the Screening and Tool for Awareness and Relief of Trauma (START).
Primary Outcome
Post Traumatic Stress Disorder Checklist - Civilian Version (PCL-C)
Interventions
- BEHAVIORAL standard of care
- BEHAVIORAL Screening Tool for Relief of Trauma (START)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-01-01 |
| Est. Completion | 2022-01-01 |
| Phase | NA |
What the finished NCT03916614 record still lists
NCT03916614 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which standard of care is the first listed.
NCT03916614 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03916614 about?
NCT03916614 is a clinical study titled "Relief of Symptoms of Post-traumatic Stress for Victims of Gun Violence". To test the hypothesis that adult individuals who are victims of gun violence will have decreased symptoms of post-traumatic stress after an individual-level intervention with the Screening and Tool for Awareness and Relief of Trauma (START).
What is the current status of trial NCT03916614?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2020-01-01. Estimated completion is 2022-01-01.
What interventions are being tested in trial NCT03916614?
The interventions under investigation include: standard of care (BEHAVIORAL), Screening Tool for Relief of Trauma (START) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03916614?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03916614's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy